sotagliflozin

Lexicon slams FDA over hearing denial following a CRL for its SGLT2 inhibitor candidate
Lexicon slams FDA over hearing denial following a CRL for its SGLT2 inhibitor candidate
Endpoints
Lexicon Pharmaceuticals
FDA
type 1 diabetes
sotagliflozin
Flag link:
Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure
Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure
Endpoints
Lexicon Pharmaceuticals
sotagliflozin
heart failure
FDA
Flag link:
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
Fierce Pharma
Lexicon Pharmaceuticals
ACC
diabetes
sotagliflozin
type 2 diabetes
heart failure
Flag link:
3 Biotech Stocks That Jumped Last Week
3 Biotech Stocks That Jumped Last Week
Motley Fool
biotech
biotech stocks
Lexicon Pharmaceuticals
sotagliflozin
Nucana
Aldeyra Therapeutics
reproxalap
Flag link:
AHA 2020 – sotagliflozin wins come too late for Lexicon
AHA 2020 – sotagliflozin wins come too late for Lexicon
EP Vantage
Lexicon Pharmaceuticals
sotagliflozin
AHA
heart failure
chronic kidney disease
Flag link:
What's Next for Lexicon Pharmaceuticals?
What's Next for Lexicon Pharmaceuticals?
Motley Fool
Lexicon Pharmaceuticals
sotagliflozin
Zynquista
Sanofi
diabetes
Flag link:
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Flag link:
Sanofi seeks to restore leadership in diabetes treatments
Sanofi seeks to restore leadership in diabetes treatments
GoinPharma
Sanofi
diabetes
sotagliflozin
Flag link:
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
Flag link:
First Oral Drug for Type 1 Diabetes Could be Available in 2018
First Oral Drug for Type 1 Diabetes Could be Available in 2018
Xtalks
type 1 diabetes
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
Flag link:
With an eye on the FDA, Lexicon and Sanofi line up more positive data on diabetes drug
With an eye on the FDA, Lexicon and Sanofi line up more positive data on diabetes drug
Endpoints
FDA
Lexicon Pharmaceuticals
Sanofi
type 1 diabetes
sotagliflozin
Flag link:
Lexicon Pharma Goes Three For Three With Sotagliflozin Data
Lexicon Pharma Goes Three For Three With Sotagliflozin Data
Seeking Alpha
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
Sanofi
Flag link:
Lexicon diabetes pill hits endpoint in another phase 3, teeing up regulatory filings by partner Sanofi
Lexicon diabetes pill hits endpoint in another phase 3, teeing up regulatory filings by partner Sanofi
Fierce Biotech
Lexicon Pharmaceuticals
diabetes
clinical trials
sotagliflozin
Sanofi
Flag link:
3 Tremendously Promising Diabetes Drugs Potentially on the Way
3 Tremendously Promising Diabetes Drugs Potentially on the Way
Motley Fool
diabetes
ertugliflozin
Merck
Pfizer
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
semaglutide
Novo Nordisk
Flag link:
Lexicon's Phase 2 Diabetes Study Looks Good
Lexicon's Phase 2 Diabetes Study Looks Good
Investopedia
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
diabetes
Flag link:
Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?
Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?
Seeking Alpha
Lexicon Pharmaceuticals
diabetes
sotagliflozin
Flag link: